Biotechnology(BK4139),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BK4139 Biotechnology

Not Yet Opened 07-31 16:00:00 EDT

77.99

-1.55

-1.94%

High79.54	Low77.52	Vol632.56M
Open79.54	D1 Closing79.54	Amplitude2.53%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O17.00B	T/O Rate--	Tradable Shares0.00
P/B7.523679	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BK4139","market":"US","secType":"PLATE","nameCN":"Biotechnology","latestPrice":77.99006,"timestamp":1785527999999,"preClose":79.53667,"halted":0,"volume":632563205,"delay":0,"changeRate":-0.019445,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-1.546608,"latestTime":"07-31 16:00:00 EDT","open":79.53667,"high":79.53673,"low":77.522385,"amount":16999438897.672815,"amplitude":0.025326,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1785763800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":7.523679,"peRate":-170.096464,"turnoverRate":0.018061,"increases":112,"decrements":391,"flats":10,"marketCap":1984351397087.125,"floatMarketCap":1816099514430.625},"requestUrl":"/m/hq/s/BK4139/wiki","defaultTab":"wiki","newsList":[{"id":"2656040321","title":"Sino Biopharmaceutical Stock Falls 1.7% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2656040321","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656040321?lang=en_us&edition=fundamental","pubTime":"2026-08-03 16:32","pubTimestamp":1785745920,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. slipped 1.7% to 4.95 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.5% to 26009.40.This was the stock's third consecutive day of losses.Sino Biopharmaceutical Ltd. closed 46% short of its 52-week high of HK$9.12, which the company reached Sept. 10.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 1.3% and Amgen Inc. remained unchanged.Trading volume totaled 58.2 million shares, compared to the 50-day average of 102.6 million shares.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","BK4599","LU2242652126.USD","IE0009355771.USD","IE00BJJMRZ35.SGD","LU1983299246.USD","IBBQ","LU0109394709.USD","LU1057294990.SGD","BK4533","PBE","LU1061106388.HKD","IE0002141913.USD","BBH","IE00BFTCPJ56.SGD","PJP","LU0889565916.HKD","LU0058720904.USD","BIB","BK4588","BK4534","BK1521","IE00BZ08YR35.GBP","BK4139","SG9999001440.SGD","01177","BK1191","BK4566","IBB","LU0289739699.SGD","BK1515","HK0000165453.HKD","BK4585","AMGN","IE00BZ08YT58.USD","LU0122379950.USD","LU1571399168.USD","LU2242646821.SGD","IE00BJT1NW94.SGD","LU2112291526.USD","LU1023059063.AUD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU0320765992.SGD","LU2468319806.SGD","LU0868494617.USD","BK1589","TBXU","LU2089984988.USD","IE00BZ08YS42.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656321864","title":"BeOne Medicines AG Expected to Post Earnings of $1.58 a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2656321864","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656321864?lang=en_us&edition=fundamental","pubTime":"2026-08-03 16:05","pubTimestamp":1785744305,"startTime":"0","endTime":"0","summary":"BeOne Medicines AG <ONC.OQ> expected to post earnings of $1.58 a share - Earnings PreviewBeOne Medicines AGONC.OQ,ONC.Ois expected to  show a rise in quarterly revenue when it reports  results on Augu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL8N4400GG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4526","BK4139","ONC","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656329064","title":"State Street Group Cuts Mesoblast Stake Below Substantial Holder Threshold","url":"https://stock-news.laohu8.com/highlight/detail?id=2656329064","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656329064?lang=en_us&edition=fundamental","pubTime":"2026-08-03 15:44","pubTimestamp":1785743076,"startTime":"0","endTime":"0","summary":"An update from Mesoblast Limited ( ($AU:MSB) ) is now available. State Street Corporation and several of its asset management subsidiaries have fil...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/state-street-group-cuts-mesoblast-stake-below-substantial-holder-threshold?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/state-street-group-cuts-mesoblast-stake-below-substantial-holder-threshold?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GABF","BK4139","BK4588","TRUF","KCE","AMGR","MESO","BCFN","BK4135","LU1894683264.USD","LU1894683348.USD","BK4585","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","IE0034235188.USD","LU0061475181.USD","LU1883839398.USD","STT","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171780891","title":"Jingdezhen IP Protection Center and Court Collaborate on Public Copyright Trial Observation","url":"https://stock-news.laohu8.com/highlight/detail?id=1171780891","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171780891?lang=en_us&edition=fundamental","pubTime":"2026-08-03 15:41","pubTimestamp":1785742864,"startTime":"0","endTime":"0","summary":"A recent public education event was held in Jingdezhen, Jiangxi Province, where the Jingdezhen Intellectual Property Protection Center partnered with the Zhushan District People's Court to conduct a...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTNT","USRD","BK4139","WRND","LRND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172865898","title":"AI is Reshaping Asia Pacific Commercial Real Estate and the Future Office, a New Report Finds","url":"https://stock-news.laohu8.com/highlight/detail?id=1172865898","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172865898?lang=en_us&edition=fundamental","pubTime":"2026-08-03 15:28","pubTimestamp":1785742123,"startTime":"0","endTime":"0","summary":"A new study from Jones Lang LaSalle reveals a complex landscape for artificial intelligence adoption in the Asia Pacific commercial real estate sector. Despite fears that AI will lead to widespread...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HAUZ","RWO","QTOC","BYRE","DRW","URE","GQRE","SRS","BLDG","ARTY","DFGR","DFAR","FPRO","AGIX","GRI","LU0029874061.USD","JRE","VGSR","RNTY","CHAT","JLL","AVRE","SRET","FREL","XLRI","REAI","CRIB","HIPS","LU0054578231.USD","IRET","LU0128526141.USD","CSRE","FREI","BK4139","BK4079","KBWY","NRO","PSR","AIPO","JPRE","SRHR","DVRE","ERET","LPRE","RINC","TRUR","ACVU","DPRE","IYRI","VTHR","BK4550","RSPR","BK4007","IQRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656252843","title":"Jefferies Cuts Ipsen to 'underperform' on Somatuline Competition Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2656252843","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656252843?lang=en_us&edition=fundamental","pubTime":"2026-08-03 15:00","pubTimestamp":1785740403,"startTime":"0","endTime":"0","summary":"BUZZ-Jefferies cuts Ipsen to 'underperform' on Somatuline competition risk** Jefferies downgrades French pharma firm IpsenIPN.PAto \"underperform\" from \"neutral,\" citing  long-term risks to its Somatul","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL6N4400DH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","IE0009355771.USD","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","LU0109394709.USD","LU0889565916.HKD","IE00BFTCPJ56.SGD","LU0320765992.SGD","IE00B2B36J28.USD","CANC","PTH","IE0002141913.USD","IE0009354923.USD","IDNA","RVMD","IE00BJJMRZ35.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153767141","title":"Meng Xiaosu | China's REITs: The Optimal Solution for Resolving Local Government Debt","url":"https://stock-news.laohu8.com/highlight/detail?id=1153767141","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153767141?lang=en_us&edition=fundamental","pubTime":"2026-08-03 14:11","pubTimestamp":1785737473,"startTime":"0","endTime":"0","summary":"Twenty years ago, when I first introduced the concept of REITs to China, few people knew what these five letters meant. Today, China's REITs market has moved beyond the pilot phase into a new era of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRI","URE","SRT.SI","BPRE","JJJ.SI","RIET","XHOA","CFA.SI","CLR.SI","BK4007","GLS.SI","TRUR","CFA","SRU.SI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656633328","title":"Sobi CEO Guido Oelkers to Step Down in Early 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2656633328","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656633328?lang=en_us&edition=fundamental","pubTime":"2026-08-03 13:33","pubTimestamp":1785735234,"startTime":"0","endTime":"0","summary":"The latest update is out from Swedish Orphan Biovitrum AB ( ($SE:SOBI) ). Swedish Orphan Biovitrum AB has announced that Chief Executive Officer Gu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sobi-ceo-guido-oelkers-to-step-down-in-early-2027?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sobi-ceo-guido-oelkers-to-step-down-in-early-2027?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIOVF","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656340500","title":"Swiss Stocks - Factors to Watch on August 3","url":"https://stock-news.laohu8.com/highlight/detail?id=2656340500","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656340500?lang=en_us&edition=fundamental","pubTime":"2026-08-03 12:57","pubTimestamp":1785733049,"startTime":"0","endTime":"0","summary":"Swiss stocks - Factors to watch on August 3ZURICH/GDANSK, Aug 3 (Reuters)-Here are some of the main factors that may affect Swiss stocks on Monday:COMPANY STATEMENTSHOLCIM AGHOLN.SSwiss building mater","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL8N43X131:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLTX","ACIU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656734085","title":"Agios Pharmaceuticals Inc : Leerink Partners Raises Target Price to $73 from $62","url":"https://stock-news.laohu8.com/highlight/detail?id=2656734085","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656734085?lang=en_us&edition=fundamental","pubTime":"2026-08-03 12:36","pubTimestamp":1785731803,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nFWN43Y0CW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","AGIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656834776","title":"Vertex Minerals Director Increases Stake via Share Purchase Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2656834776","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656834776?lang=en_us&edition=fundamental","pubTime":"2026-08-03 12:12","pubTimestamp":1785730348,"startTime":"0","endTime":"0","summary":"Vertex Minerals Ltd. ( ($AU:VTX) ) has shared an update. Vertex Minerals has disclosed a change in director Roger Jackson’s interest following his ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-minerals-director-increases-stake-via-share-purchase-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-minerals-director-increases-stake-via-share-purchase-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VRTX","IBBQ","IE00BFTCPJ56.SGD","LU0566484027.USD","LU1585245621.USD","BK4585","BBH","LU2462157665.USD","LU0417517546.SGD","BIB","IE0009355771.USD","IE00BJJMRZ35.SGD","MTX","LU2362541513.USD","LU0256863811.USD","IE00B19Z9P08.USD","SG9999013999.USD","LU2468319806.SGD","LU1674673691.USD","GNMX","VERX","LU1559883803.SGD","LU1093756168.USD","LU2362540622.SGD","LU1778281490.HKD","LU2417539215.USD","IE00B2B36J28.USD","TBXU","IBB","LU2236285917.USD","BK4567","LU1674673428.USD","IE00B894F039.SGD","LU0889565916.HKD","IE00B19Z3581.USD","IE00BZ9MQY76.HKD","LU2324357040.USD","IDNA","LU0320765992.SGD","PBE","LU0823416689.USD","BK4533","BK4139","SGXZ57979304.SGD","SG9999001176.USD","BK4109","BK4588","LU2362541273.HKD","LU0289739699.SGD","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656342208","title":"Biocon Launches Yesafili Biosimilar to Regeneron’s Eylea in US","url":"https://stock-news.laohu8.com/highlight/detail?id=2656342208","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656342208?lang=en_us&edition=fundamental","pubTime":"2026-08-03 11:34","pubTimestamp":1785728040,"startTime":"0","endTime":"0","summary":"Biocon launches Yesafili biosimilar to Regeneron’s Eylea in USBiocon Biologics launched Yesafili in the U.S., targeting a high-volume retinal disease market with an interchangeable biosimilar to Eylea","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL4Ww2Qc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","LU0320765992.SGD","LU0109394709.USD","LU0823434583.USD","LU0114720955.EUR","LU2362541513.USD","LU1974910355.USD","LU2468319806.SGD","LU2362541273.HKD","LU2362540622.SGD","LU0889565916.HKD","LU0882574055.USD","BK4139","LU2089984988.USD","LU2023250504.SGD","IBB","LU0058720904.USD","BBH","LU1917777945.USD","LU0289739699.SGD","LU2106854487.HKD","BK4585","TBXU","LU0053666078.USD","LU0823434740.USD","BK4588","LU2237438978.USD","IBBQ","REGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656479263","title":"Does Moderna’s Wider 2026 Loss Amid Pipeline Spend Change The Bull Case For MRNA?","url":"https://stock-news.laohu8.com/highlight/detail?id=2656479263","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656479263?lang=en_us&edition=fundamental","pubTime":"2026-08-03 11:30","pubTimestamp":1785727804,"startTime":"0","endTime":"0","summary":"In the past quarter, Moderna, Inc. reported second-quarter 2026 revenue of US$145 million versus US$142 million a year earlier, with a net loss of US$782 million and basic loss per share from continuing operations of US$1.97, while also updating investors on its norovirus and influenza vaccine programs.\nAcross the first half of 2026, revenue rose to US$534 million from US$250 million, but the net loss widened to US$2.13 billion and basic loss per share from continuing operations increased to...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/128680956-main-header/1756229826628","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/128680956-main-header/1756229826628"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mrna/moderna/news/does-modernas-wider-2026-loss-amid-pipeline-spend-change-the","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mrna/moderna/news/does-modernas-wider-2026-loss-amid-pipeline-spend-change-the","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MRNY","BK4532","BK4548","BK4501","MRNX","MRNA","WDNA","BK4588","GNOM","IDNA","BK4534","LGHT","BK4551","BK4533","BK4585","BK4139","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656347940","title":"Why NewAmsterdam Pharma (NAMS) Is Down 6.2% After EMA Backs Ubeslo And Evlarco Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2656347940","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656347940?lang=en_us&edition=fundamental","pubTime":"2026-08-03 11:28","pubTimestamp":1785727695,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma and Menarini Group previously announced that the EMA’s CHMP issued a positive opinion recommending marketing authorization for Ubeslo (obicetrapib 10 mg) and Evlarco (obicetrapib 10 mg plus ezetimibe 10 mg) in European patients with primary hypercholesterolemia and mixed dyslipidemia.\nThis opinion, backed by extensive Phase 2 and Phase 3 data showing meaningful LDL-C reductions with placebo-like tolerability, could reshape NewAmsterdam’s commercial outlook through...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nams/newamsterdam-pharma/news/why-newamsterdam-pharma-nams-is-down-62-after-ema-backs-ubes","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nams/newamsterdam-pharma/news/why-newamsterdam-pharma-nams-is-down-62-after-ema-backs-ubes","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","EMA","NAMS","BK4081"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656342105","title":"Inovio Pharmaceuticals Inc : Piper Sandler Cuts Target Price to $4 from $6","url":"https://stock-news.laohu8.com/highlight/detail?id=2656342105","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656342105?lang=en_us&edition=fundamental","pubTime":"2026-08-03 11:22","pubTimestamp":1785727342,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nFWN44000K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INO","BK4583","BK4568","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656944347","title":"The Bull Case For Arrowhead Pharmaceuticals (ARWR) Could Change Following Plozasiran’s Phase 3 Success And Zodasiran Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=2656944347","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656944347?lang=en_us&edition=fundamental","pubTime":"2026-08-03 10:19","pubTimestamp":1785723586,"startTime":"0","endTime":"0","summary":"Arrowhead Pharmaceuticals recently reported that its Phase 3 SHASTA-3 and SHASTA-4 trials of plozasiran in severe hypertriglyceridemia met all primary and secondary endpoints, and it also completed global Phase 3 YOSEMITE trial enrollment for zodasiran in homozygous familial hypercholesterolemia.\nThese advances signal meaningful momentum in Arrowhead’s late-stage cardiometabolic RNAi pipeline, potentially broadening future treatment options across rare and severe lipid disorders.\nNext, we’ll...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-arwr/arrowhead-pharmaceuticals/news/the-bull-case-for-arrowhead-pharmaceuticals-arwr-could-chang-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-arwr/arrowhead-pharmaceuticals/news/the-bull-case-for-arrowhead-pharmaceuticals-arwr-could-chang-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","BK4588","ARWR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182551100","title":"UK Faces Recession Risk if Strait of Hormuz Remains Closed, Analysis Warns","url":"https://stock-news.laohu8.com/highlight/detail?id=1182551100","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182551100?lang=en_us&edition=fundamental","pubTime":"2026-08-03 08:32","pubTimestamp":1785717161,"startTime":"0","endTime":"0","summary":"Consultancy firm EY analysts warned on Monday that the UK economy could contract in 2027 if the Strait of Hormuz remains closed until mid-next year.Based on an assumption that the Strait of Hormuz...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBG","TPFI","DDX","BSVO","EDGF","RJVI","FDCE","SDEF","DDXX","OBND","KNGZ","SPDG","DYFI","GCOW","GHMS","COWZ","THRV","SOVF","AHHX","FIGB","DUKH","BRHY","DYNB","SEIQ","ENDW","DVVY","TPLS","FIRI","USDX","DFSD","VMSB","LEND","HYFI","PRTO","LVIG","HFSI","BK4585","TMFM","HYI","GAL","ACSG","LCR","SCYB","RIGS","TDSC","IBHG","LENS","SCEC","FLXN","ELM","MVFG","USFI","VFMF","FLHY","JFLX","TBFC","BK4588","CIL","FIXT","AVGV","AIOO","BK4139","FTBI","NDOW","CVY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656346005","title":"LSB Industries Bets on Turnarounds and CCS Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2656346005","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656346005?lang=en_us&edition=fundamental","pubTime":"2026-08-03 08:17","pubTimestamp":1785716251,"startTime":"0","endTime":"0","summary":"Lsb Industries, Inc. (($LXU)) has held its Q2 earnings call. Read on for the main highlights of the call. LSB Industries struck an upbeat tone on i...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lsb-industries-bets-on-turnarounds-and-ccs-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lsb-industries-bets-on-turnarounds-and-ccs-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GXDW","JOYT","DECU","BK4088","LSB","PMDE","RGLO","FEBU","VGFPF","BK4139","VOTE","CCS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656460773","title":"Anika Therapeutics Lifts Outlook After Margin Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=2656460773","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656460773?lang=en_us&edition=fundamental","pubTime":"2026-08-03 08:09","pubTimestamp":1785715793,"startTime":"0","endTime":"0","summary":"Anika Therapeutics, Inc. (($ANIK)) has held its Q2 earnings call. Read on for the main highlights of the call. Anika Therapeutics’ latest earnings ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/anika-therapeutics-lifts-outlook-after-margin-surge?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/anika-therapeutics-lifts-outlook-after-margin-surge?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VGFPF","RGLO","ANIK","JOYT","FEBU","PMDE","VOTE","DECU","GXDW","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656349830","title":"AIM Vaccine Advances Serum-Free Rabies Shot Toward China Market Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2656349830","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656349830?lang=en_us&edition=fundamental","pubTime":"2026-08-03 08:09","pubTimestamp":1785715769,"startTime":"0","endTime":"0","summary":"AIM Vaccine Co., Ltd. Class H ( ($HK:6660) ) has shared an update. AIM Vaccine’s wholly owned subsidiary AIM Rongyu has completed submission of sup...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aim-vaccine-advances-serum-free-rabies-shot-toward-china-market-approval?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aim-vaccine-advances-serum-free-rabies-shot-toward-china-market-approval?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","AIM","BK4557"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":0.011},{"period":"1month","weight":0.0017},{"period":"3month","weight":0.0366},{"period":"6month","weight":0.0796},{"period":"1year","weight":0.1819},{"period":"ytd","weight":0.0955}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"name":"BK4139","nameEN":"BK4139"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.0","shortVersion":"4.47.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Biotechnology(BK4139),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Biotechnology(BK4139) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Biotechnology,BK4139,Biotechnology股票,Biotechnology股票老虎,Biotechnology股票老虎国际,Biotechnology行情,Biotechnology股票行情,Biotechnology股价,Biotechnology股市,Biotechnology股票价格,Biotechnology股票交易,Biotechnology股票购买,Biotechnology股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Biotechnology(BK4139),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Biotechnology(BK4139) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction